Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)
2017 ◽
2015 ◽
2005 ◽
Vol 359
(1-2)
◽
pp. 150-155
◽
2013 ◽
Vol 16
(2)
◽
pp. 158-165
◽
2013 ◽
2007 ◽
Vol 112
(1)
◽
pp. 89-98
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 507-507
2008 ◽
Vol 26
(15_suppl)
◽
pp. 22096-22096
◽
2010 ◽
Vol 42
◽
pp. 75